Vantas Implant 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Vantas: Implant (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

HISTRELIN (his TREL in) is a man-made protein that acts like a natural hormone in the body. It decreases testosterone in men and is used to treat advanced prostate cancer.

Similar Brand Name Drugs : Supprelin: Implant (50mg)
In-Depth Information
Select a Medication

Vantas 50mg Implant

NDC: 679790500
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Prostate Cancer

Storage Information
Protect from light
Do not freeze
Store implant refrigerated (36 to 46 degrees F), in unopened vial, overwrapped in amber plastic pouch and carton; excursions permitted to 77 degrees F for 7 days
Vantas 50mg Implant

Reported Side Effects for Vantas 50mg Implant

Increased Urination Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Diaphoresis Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Bruise Incidence:
<7.2%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
<2.8%*
Severity: MODERATE
Onset: EARLY
Flushing Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Gynecomastia Incidence:
<4.1%*
Severity: MILD
Onset: DELAYED
Bruise Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Ambras Syndrome Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Irritability Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Tiredness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Kidney Failure Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Weight Gain Incidence:
<2.3%*
Severity: MILD
Onset: DELAYED
Weight Loss Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Night Sweats Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
<2.9%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Bone Pain Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
<3.5%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Shortness Of Breath Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
<9.9%*
Severity: MILD
Onset: EARLY
Headache Incidence:
<2.9%*
Severity: MILD
Onset: EARLY
High Calcium Levels Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Sweating Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Retaining Urine Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Increased Blood Sugar Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Migraine Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Shaking Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Muscle Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
2.3%*
Severity: SEVERE
Onset: EARLY
Decreased Sexual Desire Incidence:
2.3%*
Severity: MILD
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
3.5%*
Severity: MODERATE
Onset: DELAYED
Testicular Atrophy Incidence:
5.3%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
5.8-51.1%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Second Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Third Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Vantas

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5